Please use this identifier to cite or link to this item:
http://hdl.handle.net/1843/42592
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Jamille Fernandes Lula | pt_BR |
dc.creator | Bruna Mara Aparecida de Carvalho Mesquita | pt_BR |
dc.creator | Leandro de Freitas Teles | pt_BR |
dc.creator | Sérgio Henrique Sousa Santos | pt_BR |
dc.creator | Alfredo Maurício Batista de Paula | pt_BR |
dc.creator | André Luiz Sena Guimaraes | pt_BR |
dc.creator | Erivelton Pereira dos Santos | pt_BR |
dc.creator | Deborah de Farias Lelis | pt_BR |
dc.creator | Luís Paulo Oliveira | pt_BR |
dc.creator | Lucyana Conceição Farias | pt_BR |
dc.creator | Igor Viana Brandi | pt_BR |
dc.creator | Karla Nayara de Oliveira Santana | pt_BR |
dc.date.accessioned | 2022-06-22T12:43:09Z | - |
dc.date.available | 2022-06-22T12:43:09Z | - |
dc.date.issued | 2017 | - |
dc.citation.volume | 14 | pt_BR |
dc.citation.issue | 2 | pt_BR |
dc.citation.spage | 114 | pt_BR |
dc.citation.epage | 119 | pt_BR |
dc.identifier.doi | http://doi.org/10.2174/1573408014666171220152537 | pt_BR |
dc.identifier.issn | 1875-6662 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/1843/42592 | - |
dc.description.resumo | Background: Obesity is an important risk factor for nonalcoholic fatty liver disease which varies from hepatic steatosis to liver cirrhosis. Interventions in weight and metabolic control are important in reducing steatosis risk. Aims: The aim of the present study was to investigate the role of celecoxib in hepatic triacylglycerol deposition in non-alcoholic fatty liver disease exploring the signaling involved in obese mice lipogenesis. Methods: Males FVB/N mice were allocated into three groups and were fed with experimental diets: standard, a high-fat diet or a high-fat diet along with Cox-2 inhibitor treatment (Celecoxib; 100mg/kg of body weight). The body weight, food intake, blood parameters and liver histology were analyzed. Expression of liver lipogenesis-related genes (ACC, PPAR-γ, FAS, SREBP-1c) was evaluated by quantitative real-time PCR. Results: The main findings showed that celecoxib treatment resulted in body weight loss in obese animals, reduced food consumption and decreased triglycerides. ACC, FAS and SREBP1-c mRNA expression was significantly suppressed in HFD+ICOX-2 fed mice. Conclusion: Celecoxib improved lipid metabolism and decreased fat deposition in the liver of obese mice by reducing lipogenesis, which may be a promising therapeutic target for liver disorders, obesity and its comorbidities. | pt_BR |
dc.language | eng | pt_BR |
dc.publisher | Universidade Federal de Minas Gerais | pt_BR |
dc.publisher.country | Brasil | pt_BR |
dc.publisher.department | ICA - INSTITUTO DE CIÊNCIAS AGRÁRIAS | pt_BR |
dc.publisher.initials | UFMG | pt_BR |
dc.relation.ispartof | Current Enzyme Inhibition | pt_BR |
dc.rights | Acesso Restrito | pt_BR |
dc.subject.other | Analgésicos | pt_BR |
dc.subject.other | Enzimas | pt_BR |
dc.subject.other | Inibidores enzimáticos | pt_BR |
dc.subject.other | Agentes anti-inflamatórios | pt_BR |
dc.subject.other | Fígado gorduroso | pt_BR |
dc.subject.other | Obesidade | pt_BR |
dc.title | Cox enzyme inhibitor, celecoxib, reduces steatosis and liver lipogenesis in high-fat fed mice | pt_BR |
dc.type | Artigo de Periódico | pt_BR |
dc.url.externa | http://www.eurekaselect.com/article/87479 | pt_BR |
dc.identifier.orcid | https://orcid.org/ 0000-0001-8980-8599 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0001-6714-7996 | pt_BR |
Appears in Collections: | Artigo de Periódico |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.